TCR2 Therapeutics Inc. (TCRR)
NASDAQ: TCRR
· Real-Time Price · USD
1.48
0.00 (0.00%)
At close: May 31, 2023, 10:00 PM
TCR2 Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 14.45M | 32.75M | 54.01M | 44.21M | 74.12M | 222.56M | 262.5M | 248.79M | 218.28M |
Short-Term Investments | 95.86M | 116.43M | 121.98M | 162.03M | 158.07M | 43.03M | 33.24M | 68.55M | 115M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.87M | 1.94M | 2.06M | 2.21M | 1.95M | 1.89M | 1.82M | 1.63M | 1.37M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 8.82M | 5.16M | 8.09M | 9.59M | 15.12M | 10.53M | 7.48M | 7.88M | 9.69M |
Total Current Assets | 140.49M | 177.62M | 184.08M | 215.83M | 247.3M | 276.13M | 303.22M | 325.23M | 342.97M |
Property-Plant & Equipment | 9.15M | 28.68M | 86.79M | 90M | 74M | 45.36M | 41.68M | 41.28M | 51.84M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 11.02M | 30.61M | 88.85M | 92.21M | 75.94M | 47.24M | 43.51M | 42.91M | 53.21M |
Total Assets | 151.51M | 208.24M | 272.93M | 308.04M | 323.25M | 323.37M | 346.72M | 368.14M | 396.18M |
Account Payables | 6.32M | 2.79M | 2.96M | 5.47M | 4.48M | 2.14M | 4.38M | 4.82M | 3.83M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 3.27M | 50.45M | 20.55M | 20.57M | 16.93M | 3.37M | 3.48M | 3.59M | 2.11M |
Other Current Liabilities | 37.88M | 10.82M | 13.19M | 12.53M | 9.45M | 13.09M | 8.65M | 6.53M | 4.58M |
Total Current Liabilities | 47.47M | 64.06M | 36.69M | 38.57M | 30.87M | 18.61M | 16.52M | 14.95M | 10.52M |
Long-Term Debt | 2.71M | 3.32M | 37.68M | 43.21M | 36.75M | 23M | 23.64M | 24.05M | 35.01M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 313K | 293K | 299K | 257K | 892K |
Total Long-Term Liabilities | 2.71M | 3.32M | 37.68M | 43.21M | 37.06M | 23.29M | 23.93M | 24.3M | 35.9M |
Total Liabilities | 50.18M | 67.38M | 74.38M | 81.78M | 67.93M | 41.89M | 40.45M | 39.25M | 46.42M |
Total Debt | 5.98M | 53.76M | 58.23M | 63.78M | 53.68M | 26.36M | 27.12M | 27.64M | 37.13M |
Common Stock | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Retained Earnings | -541.74M | -501.34M | -440.84M | -410.25M | -378.64M | -349.52M | -321.78M | -295.54M | -271.23M |
Comprehensive Income | -188K | -445K | -596K | -671K | -344K | -13K | -15K | -19K | -44K |
Shareholders Equity | 101.33M | 140.86M | 198.55M | 226.26M | 255.32M | 281.48M | 306.27M | 328.89M | 349.75M |
Total Investments | 95.86M | 116.43M | 121.98M | 162.03M | 158.07M | 43.03M | 33.24M | 68.55M | 115M |